Daxor Receives U.S. Patent For Remote Blood Volume Monitor

Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas

Daxor Corporation announced the launch of a new outpatient Blood Volume Analysis (BVA) program at a healthcare facility in eastern Kansas through its turnkey ezBVA Lab send-out model. The service provides 98% accurate blood volume measurements within 24 hours without requiring capital equipment, enabling clinicians to optimize decongestion strategies and reduce hospital readmissions.

Reported Earlier, Daxor Broadens Outpatient Diagnostics As Kansas Health System Adopts CLIA-Certified ezBVA Lab Blood Volume Analysis Service

Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas

Daxor Corporation will exhibit its FDA-cleared Blood Volume Analyzer (BVA) for the first time at the 14th Annual Dysautonomia International Conference (July 9-12, 2026) in Texas. The company emphasizes how BVA provides objective plasma and red blood cell data to improve dysautonomia therapy, representing a shift from subjective symptom tracking to precision, data-driven diagnostics.